Abstract
Rationale
The common methionine (met) for valine (val) at codon 158 (val158met) polymorphism in the catechol-O-methyltransferase (COMT) gene has been associated with nicotine dependence, alterations in executive cognitive function, and abstinence-induced working memory deficits in smokers.
Objectives
We sought to replicate the association of the COMT val allele with abstinence-induced alterations in working memory-related activity in task-positive (executive control) and task-negative (default mode network) regions.
Methods
Forty smokers (20 val/val and 20 met/met) performed an N-back task while undergoing blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI) on two separate occasions: following 72 h of confirmed abstinence and during smoking as usual. An independent sample of 48 smokers who completed the identical N-back task during fMRI in smoking vs. abstinence for another study was used as a validation sample.
Results
Contrary to expectations, genotype by session interactions on BOLD signal in executive control regions (dorsolateral prefrontal cortex and dorsal cingulate/medial prefrontal cortex) revealed significant abstinence-induced reductions in the met/met group, but not the val/val group. Results also revealed that val/val smokers may exhibit less suppression of activation in task-negative regions such as the posterior cingulate cortex during abstinence (vs. smoking). These patterns were confirmed in the validation sample and in the whole-brain analysis, though the regions differed from the a priori regions of interest (ROIs) (e.g., precuneus, insula).
Conclusions
The COMT val158met polymorphism was associated with abstinence-related working memory deficits in two independent samples of smokers. However, inconsistencies compared to prior findings and across methods (ROI vs. whole-brain analysis) highlight the challenges inherent in reproducing results of imaging genetic studies in addiction.
Similar content being viewed by others
References
Anticevic A, Cole MW, Murray JD, Corlett PR, Wang XJ, Krystal JH (2012) The role of default network deactivation in cognition and disease. Trends Cogn Sci 16:584–592
Ashare RL, Hawk LW Jr (2012) Effects of smoking abstinence on impulsive behavior among smokers high and low in ADHD-like symptoms. Psychopharmacology (Berl) 219:537–547
Barnett JH, Scoriels L, Munafo MR (2008) Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry 64:137–144
Beckmann CF, Smith SM (2004) Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Trans Med Imaging 23:137–152
Berryhill ME, Wiener M, Stephens JA, Lohoff FW, Coslett HB (2013) COMT and ANKK1-Taq-Ia genetic polymorphisms influence visual working memory. PLoS One 8:e55862
Bertolino A, Blasi G, Latorre V, Rubino V, Rampino A, Sinibaldi L, Caforio G, Petruzzella V, Pizzuti A, Scarabino T, Nardini M, Weinberger DR, Dallapiccola B (2006) Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurosci 26:3918–3922
Brady KT, Gray KM, Tolliver BK (2011) Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav 99:285–294
Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT (2006) Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry 63:808–816
Caldu X, Vendrell P, Bartres-Faz D, Clemente I, Bargallo N, Jurado MA, Serra-Grabulosa JM, Junque C (2007) Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. NeuroImage 37:1437–1444
Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807–821
Cole DM, Beckmann CF, Long CJ, Matthews PM, Durcan MJ, Beaver JD (2010) Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics. NeuroImage 52:590–599
Colilla S, Lerman C, Shields PG, Jepson C, Rukstalis M, Berlin J, DeMichele A, Bunin G, Strom BL, Rebbeck TR (2005) Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet Genomics 15:393
Cox LS, Tiffany ST, Christen AG (2001) Evaluation of the brief Questionnaire of Smoking Urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 3:7–16
Culhane MA, Schoenfeld DA, Barr RS, Cather C, Deckersbach T, Freudenreich O, Goff DC, Rigotti NA, Evins EA (2008) Predictors of early abstinence in smokers with schizophrenia. J Clin Psychiatry 69(11):1743–1750
Dang LC, O'Neil JP, Jagust WJ (2013) Genetic effects on behavior are mediated by neurotransmitters and large-scale neural networks. NeuroImage 66C:203–214
Davis JA, James JR, Siegel SJ, Gould TJ (2005) Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. J Neurosci 25:8708–8713
Dolan SL, Sacco KA, Termine A, Seyal AA, Dudas MM, Vessicchio JC, Wexler BE, George TP (2004) Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia. Schizophr Res 70:263–275
Falcone M, Wileyto EP, Ruparel K, Gerraty RT, Laprate L, Detre JA, Gur R, Loughead J, Lerman C (2013) Age-related differences in working memory deficits during nicotine withdrawal. Addict Biol. doi:10.1111/adb.12051
Goldberg TE, Weinberger DR (2004) Genes and the parsing of cognitive processes. Trends Cogn Sci 8:325–335
Harrison EL, Coppola S, McKee SA (2009) Nicotine deprivation and trait impulsivity affect smokers' performance on cognitive tasks of inhibition and attention. Exp Clin Psychopharmacol 17:91–98
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 86:1119–1127
Hughes J, Hatsukami D, Pickens R, Krahn D, Malin S, Luknic A (1984) Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology (Berl) 83:82–87
Hughes JR (2007) Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 9:315–327
Jacobsen LK, Krystal JH, Mencl WE, Westerveld M, Frost SJ, Pugh KR (2005) Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry 57:56–66
Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 17:825–841
Jenkinson M, Smith S (2001) A global optimisation method for robust affine registration of brain images. Med Image Anal 5:143–156
Johnstone EC, Elliot KM, David SP, Murphy MF, Walton RT, Munafo MR (2007) Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev 16:1065–1069
Krishnan-Sarin S, Reynolds B, Duhig AM, Smith A, Liss T, McFetridge A, Cavallo DA, Carroll KM, Potenza MN (2007) Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend 88:79–82
Lerman C, LeSage MG, Perkins KA, O'Malley SS, Siegel SJ, Benowitz NL, Corrigall WA (2007) Translational research in medication development for nicotine dependence. Nat Rev Drug Discov 6:746–762
Lerman, C., Perkins, K.A., Gould, T., 2008. Nicotine dependence endophenotypes in chronic smokers. National Cancer Institute. Phenotypes and endophenotypes: foundations for genetic studies of nicotine use and dependence. Tobacco Control Monograph No. 20. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. NIH Publication No. 08–6366
Liu ME, Hong CJ, Liou YJ, Tsai YL, Hsieh CH, Tsai SJ (2008) Association study of a functional catechol-O-methyltransferase polymorphism and executive function in elderly males without dementia. Neurosci Lett 436:193–195
Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, Gur RC, Lerman C (2010) Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry 67:715–721
Loughead J, Wileyto EP, Valdez JN, Sanborn P, Tang K, Strasser AA, Ruparel K, Ray R, Gur RC, Lerman C (2009) Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype. Mol Psychiatry 14:820–826
Mendrek A, Monterosso J, Simon SL, Jarvik M, Brody A, Olmstead R, Domier CP, Cohen MS, Ernst M, London ED (2006) Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence. Addict Behav 31:833–844
Mier D, Kirsch P, Meyer-Lindenberg A (2010) Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry 15:918–927
Munafo MR, Johnstone EC, Guo B, Murphy MF, Aveyard P (2008) Association of COMT Val108/158Met genotype with smoking cessation. Pharmacogenet Genomics 18:121–128
Mutschler J, Abbruzzese E, von der Goltz C, Dinter C, Mobascher A, Thiele H, Diaz-Lacava A, Dahmen N, Gallinat J, Majic T, Petrovsky N, Thuerauf N, Kornhuber J, Grunder G, Rademacher L, Brinkmeyer J, Wienker T, Wagner M, Winterer G, Kiefer F (2013) Lack of association of a functional catechol-O-methyltransferase gene polymorphism with risk of tobacco smoking: results from a multicenter case–control study. Nicotine Tob Res 15(7):1322–7
Myers CS, Richard CT, Etter JR, Moolchan ET, Heishman SJ (2005) Nicotine nasal spray dose-dependently enhanced sustained attention as assessed by the continuous performance task. Society for Research on Nicotine and Tobacco, Prague
Myers CS, Taylor RC, Moolchan ET, Heishman SJ (2008) Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray. Neuropsychopharmacology 33:588–598
Nedic G, Nikolac M, Borovecki F, Hajnsek S, Muck-Seler D, Pivac N (2010) Association study of a functional catechol-O-methyltransferase polymorphism and smoking in healthy Caucasian subjects. Neurosci Lett 473:216–219
Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8:1445–1449
Patterson F, Jepson C, Loughead J, Perkins K, Strasser A, Siegel S, Frey J, Gur R, Lerman C (2010) Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend 106:61–64
Patterson F, Jepson C, Strasser AA, Loughead J, Perkins KA, Gur RC, Frey JM, Siegel S, Lerman C (2009) Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry 65:144–149
Pomarol-Clotet E, Fatjo-Vilas M, McKenna PJ, Monte GC, Sarro S, Ortiz-Gil J, Aguirre C, Gomar JJ, Guerrero A, Landin R, Capdevila A, Fananas L, Salvador R (2010) COMT Val158Met polymorphism in relation to activation and de-activation in the prefrontal cortex: a study in patients with schizophrenia and healthy subjects. NeuroImage 53:899–907
Portugal GS, Gould TJ (2007) Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning. Pharmacol Biochem Behav 88:179–187
Ragland JD, Turetsky BI, Gur RC, Gunning-Dixon F, Turner T, Schroeder L, Chan R, Gur RE (2002) Working memory for complex figures: an fMRI comparison of letter and fractal n-back tasks. Neuropsychology 16:370
Raybuck JD, Portugal GS, Lerman C, Gould TJ (2008) Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice. Behav Neurosci 122:1166–1171
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59(Suppl 20):22–33, quiz 34–57
Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143–155
Sofuoglu M (2010) Cognitive enhancement as a pharmacotherapy target for stimulant addiction. Addiction 105:38–48
Stokes PR, Rhodes RA, Grasby PM, Mehta MA (2011) The effects of the COMT Val108/158Met polymorphism on BOLD activation during working memory, planning, and response inhibition: a role for the posterior cingulate cortex? Neuropsychopharmacology 36:763–771
Sutherland MT, McHugh MJ, Pariyadath V, Stein EA (2012) Resting state functional connectivity in addiction: lessons learned and a road ahead. NeuroImage 62:2281–2295
Tammimaki AE, Mannisto PT (2010) Are genetic variants of COMT associated with addiction? Pharmacogenet Genomics 20:717–741
Tan HY, Chen Q, Goldberg TE, Mattay VS, Meyer-Lindenberg A, Weinberger DR, Callicott JH (2007) Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory. J Neurosci 27:13393–13401
Tost H, Bilek E, Meyer-Lindenberg A (2012) Brain connectivity in psychiatric imaging genetics. NeuroImage 62(4):2250–2260
Tunbridge EM (2010) The catechol-O-methyltransferase gene: its regulation and polymorphisms. Int Rev Neurobiol 95:7–27
Tunbridge EM, Harrison PJ (2011) Importance of the COMT gene for sex differences in brain function and predisposition to psychiatric disorders. Curr Top Behav Neurosci 8:119–140
Tunbridge EM, Harrison PJ, Weinberger DR (2006) Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 60:141–151
Ward MM, Swan GE, Jack LM (2001) Self-reported abstinence effects in the first month after smoking cessation. Addict Behav 26:311–327
Wardle MC, de Wit H, Penton-Voak I, Lewis G, Munafo MR (2013) Lack of association between COMT and working memory in a population-based cohort of healthy young adults. Neuropsychopharmacology 38(7):1253–63
Winterer G, Goldman D (2003) Genetics of human prefrontal function. Brain research 43:134–163
Winterer G, Musso F, Vucurevic G, Stoeter P, Konrad A, Seker B, Gallinat J, Dahmen N, Weinberger DR (2006) COMT genotype predicts BOLD signal and noise characteristics in prefrontal circuits. NeuroImage 32:1722–1732
Winterer G, Weinberger DR (2004) Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27:683–690
Woolrich MW, Ripley BD, Brady M, Smith SM (2001) Temporal autocorrelation in univariate linear modeling of FMRI data. NeuroImage 14:1370–1386
Yavich L, Forsberg MM, Karayiorgou M, Gogos JA, Mannisto PT (2007) Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci 27:10196–10209
Zachary RS (2000) Shipley Institute of Living Scale: revised manual. Western Psychological Services, Los Angeles
Acknowledgments
This research was supported by grants R03 DA027438 (CL) and R01 DA026849 (CL) and pilot funding from UL1 RR024134 (RLA). The NIH had no further role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOC 365 kb)
Rights and permissions
About this article
Cite this article
Ashare, R.L., Valdez, J.N., Ruparel, K. et al. Association of abstinence-induced alterations in working memory function and COMT genotype in smokers. Psychopharmacology 230, 653–662 (2013). https://doi.org/10.1007/s00213-013-3197-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-013-3197-3